source
- FDA panel backs compounding pharmacies to make two peptides, rejects thirdThe U.S. Food and Drug Administration’s advisory committee met on Friday and issued recommendations on the manufacturing of certain peptide drugs by compounding pharmacies. Committee members voted…
- Sarepta appoints Michael Severino as CEO to steer company beyond a turbulent yearSarepta Therapeutics announced that Michael Severino will become its chief executive officer, taking over from longtime leader Doug Ingram. Severino is slated to start on Tuesday and joins the com…